Search Results 321-330 of 13742 for monoclonal antibody
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...
... monoclonal antibody fragment," says Dr. Bakri. "The expressed protein is designed to neutralize vascular endothelial growth factor (VEGF) activity. Anti ...
Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find ...
Lack of observed interference by therapeutic monoclonal antibodies ... Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and ...
HER2 protein is produced by some tumors. Pertuzumab is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by ...
Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Has had a prior anti-cancer monoclonal antibody (mAb) ≤4 weeks prior to ...
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. ... * Whether the body makes antibodies ...
Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Immunotherapy with monoclonal antibodies, such as ...
Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2. This may restrain new blood vessel formation therefore ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.